Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M125,902Revenue $M32,639Net Margin (%)55.5Altman Z-Score5.1
Enterprise Value $M132,943EPS $11.9Operating Margin %68.0Piotroski F-Score8
P/E(ttm)8.0Beneish M-Score-1.9Pre-tax Margin (%)66.4Higher ROA y-yY
Price/Book6.910-y EBITDA Growth Rate %--Quick Ratio2.6Cash flow > EarningsY
Price/Sales4.45-y EBITDA Growth Rate %27.2Current Ratio2.8Lower Leverage y-yN
Price/Free Cash Flow7.7y-y EBITDA Growth Rate %81.7ROA % (ttm)42.2Higher Current Ratio y-yY
Dividend Yield %1.5PEG0.3ROE % (ttm)106Less Shares Outstanding y-yY
Payout Ratio %8.0Shares Outstanding M1,441ROIC % (ttm)128Gross Margin Increase y-yY

Gurus Latest Trades with GILD

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GILDT Rowe Price Equity Income Fund 2015-12-31 Buy 0.57%$97.54 - $110.96
($104.15)
$ 87.36-16%New holding1,250,000
GILDMario Gabelli 2015-12-31 Reduce$97.54 - $110.96
($104.19)
$ 87.36-16%Reduce -2.40%42,700
GILDKen Fisher 2015-12-31 Add$97.54 - $110.96
($104.15)
$ 87.36-16%Add 0.27%563,917
GILDRonald Muhlenkamp 2015-12-31 Reduce$97.54 - $110.96
($104.19)
$ 87.36-16%Reduce -0.01%217,975
GILDJulian Robertson 2015-09-30 Reduce-0.78%$94.8 - $119.6
($111.06)
$ 87.36-21%Reduce -11.79%352,311
GILDJohn Rogers 2015-09-30 Add0.25%$94.8 - $119.6
($111.06)
$ 87.36-21%Add 18.71%1,313,500
GILDJoel Greenblatt 2015-09-30 Reduce-0.13%$94.8 - $119.6
($111.06)
$ 87.36-21%Reduce -12.28%936,982
GILDJohn Keeley 2015-09-30 Buy 0.08%$94.8 - $119.6
($111.06)
$ 87.36-21%New holding29,029
GILDKen Fisher 2015-09-30 Reduce-0.06%$94.8 - $119.6
($111.06)
$ 87.36-21%Reduce -28.96%562,391
GILDNWQ Managers 2015-09-30 Add0.04%$94.8 - $119.6
($111.06)
$ 87.36-21%Add 16.74%169,500
GILDDavid Dreman 2015-09-30 Add0.02%$94.8 - $119.6
($111.06)
$ 87.36-21%Add 17.88%11,228
GILDRonald Muhlenkamp 2015-09-30 Reduce-0.02%$94.8 - $119.6
($111.06)
$ 87.36-21%Reduce -0.29%217,990
GILDMario Gabelli 2015-09-30 Reduce$94.8 - $119.6
($111.06)
$ 87.36-21%Reduce -0.40%43,750
GILDJulian Robertson 2015-06-30 Add2.77%$97.72 - $122.21
($109.1)
$ 87.36-20%Add 72.52%399,411
GILDJohn Rogers 2015-06-30 Add0.28%$97.72 - $122.21
($109.1)
$ 87.36-20%Add 24.10%1,106,494
GILDNWQ Managers 2015-06-30 Add0.05%$97.72 - $122.21
($109.1)
$ 87.36-20%Add 28.38%145,200
GILDDavid Dreman 2015-06-30 Add0.04%$97.72 - $122.21
($109.1)
$ 87.36-20%Add 70.70%9,525
GILDJoel Greenblatt 2015-06-30 Reduce-0.03%$97.72 - $122.21
($109.1)
$ 87.36-20%Reduce -3.58%1,068,128
GILDRonald Muhlenkamp 2015-06-30 Reduce$97.72 - $122.21
($109.1)
$ 87.36-20%Reduce -0.05%218,620
GILDKen Fisher 2015-06-30 Add$97.72 - $122.21
($109.1)
$ 87.36-20%Add 0.26%791,630
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GILD is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


GILD: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MARTIN JOHN CChairman and CEO 2016-02-01Sell100,000$83.424.72view
Carter Paul RutherfordEVP Commercial Ops 2016-02-01Sell2,000$82.326.12view
MARTIN JOHN CChairman and CEO 2016-01-04Sell100,000$97.68-10.57view
Carter Paul RutherfordEVP Commercial Ops 2016-01-04Sell2,000$99.2-11.94view
BISCHOFBERGER NORBERT WEVP, R&D and CSO 2015-12-15Sell70,000$102.41-14.7view
MILLIGAN JOHN FPresident and COO 2015-12-07Sell100,000$103.18-15.33view
MARTIN JOHN CChairman and CEO 2015-12-01Sell150,000$105.82-17.44view
Alton Gregg HEVP, Corp & Med Affairs 2015-12-01Sell12,000$106.01-17.59view
Carter Paul RutherfordEVP Commercial Ops 2015-12-01Sell2,000$106.38-17.88view
Whitley Richard JamesDirector 2015-11-24Sell8,546$107.04-18.39view

Quarterly/Annual Reports about GILD:

    News about GILD:

    Articles On GuruFocus.com
    Gilead, Johnson & Johnson or Roche? Feb 11 2016 
    Jeff Auxier Takes Plunge in Fastenal, a Stock From Watchlist Feb 10 2016 
    Plenty of Opportunity to Buy Individual Stocks: John Buckingham Feb 02 2016 
    Apple: Think Differently From the Analysts Feb 01 2016 
    10 Fund Managers Are Totally Wrong on GlaxoSmithKline Jan 26 2016 
    The Best Reason to Love Gilead's Market Correction Jan 18 2016 
    Gurus Are Buying These Stocks Trading Below Peter Lynch value Jan 14 2016 
    Best Ideas Contest 2016, Win $1000 Jan 28 2016 
    Berkshire Hathaway: Dividends Are Coming; Why Not In 2016? Dec 31 2015 
    Here are My Top Ten Stock Picks for 2016 Dec 30 2015 

    More From Other Websites
    [$$] Gilead Way Oversold As Investors Flee Biotech Feb 11 2016
    Morgan Stanley is Wrong: This Biotech is Ready to Explode Higher Feb 11 2016
    John Elway's Lost Bronco Riches And The Miracle of Compounding Feb 11 2016
    Gilead Sciences: Can New CEO 'Re-Energize' Sleeping Giant? Feb 11 2016
    Most Searched Tickers Among Financial Advisors: Apple and Alphabet Share the Lead; Focus on Tech,... Feb 11 2016
    Gilead (GILD) Stock Gains, Barclays Sees Upside Potential for Hep-C Drugs Feb 10 2016
    Relypsa: This Biotech Just Released Stunning Data Feb 10 2016
    Gilead Sciences: A Good Set Up for Earnings Beats? Feb 10 2016
    Major Biotech Short Interest Continues to Be Mixed Feb 10 2016
    Icahn, Gilead, GE Lead Top Insider Trades Of The Week Feb 09 2016
    Biotech ETFs Slide as Stocks Report Mixed Q4 Results Feb 09 2016
    What Investors Can Expect from Healthcare Sector Companies Feb 09 2016
    Rebound For Big Biotech ETF Will Require Some Patience Feb 09 2016
    [$$] Overheard: Biotech Waiting Game Still Paying Off for Gilead Feb 09 2016
    [$$] OVERHEARD Feb 08 2016
    Gilead Sciences to Participate in Two Upcoming Investor Conferences Feb 08 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK